← Surgery Partners, Inc.
| Annual Trend | FY 2015 | FY 2016 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Revenue | $959.9m |
$1.1b
+19.33%
|
$1.8b
+54.65%
|
$1.8b
+3.38%
|
$1.9b
+1.57%
|
$2.2b
+19.62%
|
$2.5b
+14.12%
|
$2.7b
+8.03%
|
$3.1b
+13.52%
|
$3.3b
+6.24%
|
$3.3b
+1.05%
|
|
| Cost of Goods and Services Sold | $669.3m |
$821.2m
+22.69%
|
$1.4b
+65.79%
|
$1.4b
+3.39%
|
$1.5b
+5.16%
|
$1.7b
+17.12%
|
$2.0b
+13.31%
|
$2.1b
+6.69%
|
$2.4b
+13.02%
|
$2.5b
+7.39%
|
$2.6b
+1.44%
|
|
| Cost Of Revenue | $669.3m |
$821.2m
+22.69%
|
$1.4b
+65.79%
|
$1.4b
+3.39%
|
$1.5b
+5.16%
|
$1.7b
+17.12%
|
$2.0b
+13.31%
|
$2.1b
+6.69%
|
$2.4b
+13.02%
|
$2.5b
+7.39%
|
$2.6b
+1.44%
|
|
| Gross Profit | $290.6m |
$324.2m
+11.59%
|
$410.0m
+26.46%
|
$423.8m
+3.36%
|
$379.8m
-10.38%
|
$491.4m
+29.38%
|
$574.9m
+16.99%
|
$647.5m
+12.63%
|
$745.6m
+15.15%
|
$765.0m
+2.60%
|
$763.3m
-0.22%
|
|
| Net Interest Income | ($101.0m) | ($100.6m) | ($147.0m) | ($178.9m) | ($201.8m) | ($221.0m) |
($234.9m)
-6.29%
|
($193.0m)
+17.84%
|
($201.7m)
-4.51%
|
($272.6m)
-35.15%
|
($279.5m)
-2.53%
|
|
| General and Administrative Expense | $56.0m | $60.2m | $93.6m | $88.6m | $97.1m | $104.0m | $102.2m | $120.9m | $138.7m | $118.2m | $121.5m | |
| Labor and Related Expense | $261.7m | $357.2m | $534.7m | $550.0m | $550.3m | $644.3m | $746.4m | $793.8m | $907.5m | $971.0m | — | |
| Amortization of Intangible Assets | $9.1m | $9.6m | $4.9m | $4.6m | $4.3m | $4.3m | $6.4m | $7.6m | $8.7m | $6.1m | — | |
| Restructuring And Mergern Acquisition | $17.9m | $8.7m | $31.7m | $19.0m | $23.2m | $39.8m | $47.5m | $61.7m | $100.1m | $73.9m | $64.8m | |
| Operating Lease, Expense | — | — | — | — | $39.4m | $39.1m | $34.8m | $35.2m | $38.9m | $37.8m | — | |
| Operating Costs and Expenses | $669.3m | $821.2m | $1.4b | $1.4b | $1.5b | $1.7b | $2.0b | $2.1b | $2.4b | $2.5b | — | |
| Other Operating Expenses | — | — | — | — | — | ($37.9m) | ($2.4m) | ($1.1m) | — | — | — | |
| Other operating expenses | $54.1m | $61.5m | $104.3m | $109.3m | $112.8m | $132.4m | $156.7m | $175.3m | $201.7m | $201.4m | — | |
| Operating Expenses | $815.1m | $949.0m | $1.7b | $1.6b | $1.7b | $1.9b | $2.2b | $2.4b | $2.8b | $2.9b | $2.9b | |
| EBIT | $144.8m | $196.5m | $77.8m | $235.9m | $183.0m | $302.2m | $345.2m | $328.0m | $348.8m | $389.5m | $393.4m | |
| Operating Income | $144.8m |
$196.5m
+35.74%
|
$77.8m
-60.38%
|
$235.9m
+203.07%
|
$183.0m
-22.42%
|
$302.2m
+65.14%
|
$357.9m
+18.43%
|
$408.5m
+14.14%
|
$454.3m
+11.21%
|
$470.8m
+3.63%
|
$465.3m
-1.17%
|
|
| Other Non Operating Income Expenses | — | — | — | — | — | — | $19.0m | $7.5m | $20.0m | $8.7m | — | |
| Operating Income (Loss) | $144.8m |
$196.5m
+35.74%
|
$77.8m
-60.38%
|
$235.9m
+203.07%
|
$183.0m
-22.42%
|
$302.2m
+65.14%
|
$345.2m
+14.23%
|
$328.0m
-4.98%
|
$348.8m
+6.34%
|
$389.5m
+11.67%
|
$465.3m
+19.46%
|
|
| Interest Expense | $101.0m | $100.6m | $147.0m | $178.9m | $201.8m | $221.0m | $234.9m | $193.0m | $201.7m | $272.6m | $279.5m | |
| Net Non Operating Interest Income Expense | ($101.0m) | ($100.6m) | ($147.0m) | ($178.9m) | ($201.8m) | ($221.0m) | ($234.9m) | ($193.0m) | ($201.7m) | ($272.6m) | ($279.5m) | |
| Gain (Loss) Related to Litigation Settlement | — | $14.1m | ($46.0m) | ($200k) | ($1.2m) | $0 | $29.3m | ($10.6m) | $800k | ($7.3m) | — | |
| Gain On Sale Of Business | — | — | — | — | — | — | ($11.1m) | ($14.4m) | ($40.6m) | ($30.4m) | ($28.3m) | |
| Gain On Sale Of PPE | — | — | — | — | — | ($2.2m) | ($11.1m) | — | — | — | — | |
| Income (Loss) from Equity Method Investments | $3.8m | $4.8m | $8.9m | $10.2m | $10.8m | $11.3m | $12.5m | $14.2m | $19.5m | $22.9m | — | |
| Other income, net | ($525k) | $55k | ($3.8m) | ($1.4m) | ($1.7m) | ($15.5m) | ($16.6m) | ($6.4m) | ($20.0m) | ($8.7m) | ($71.9m) | |
| Other Nonoperating Income (Expense) | — | — | — | — | — | — | — | $8.6m | — | — | — | |
| Other Income Expense | — | — | — | — | — | — | ($12.7m) | ($80.5m) | ($105.5m) | ($81.3m) | ($71.9m) | |
| Interest Income (Expense), Nonoperating, Net | ($101.0m) | ($100.6m) | ($147.0m) | ($178.9m) | ($201.8m) | ($221.0m) | ($234.9m) | ($193.0m) | ($201.7m) | ($272.6m) | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | ($76.1m) | $92.2m | ($69.2m) | $54.6m | ($18.8m) | $81.2m | $110.3m | $135.0m | $147.1m | $116.9m | $113.9m | |
| Pre-Tax Income | ($76.1m) | $92.2m | ($69.2m) | $54.6m | ($18.8m) | $81.2m | $110.3m | $135.0m | $147.1m | $116.9m | $113.9m | |
| Income Tax Expense (Benefit) | ($149.0m) | $7.1m | $26.5m | $9.5m | ($20.1m) | $10.5m | $23.3m | ($300k) | $134.6m | $18.0m | $16.8m | |
| Net Income From Continuing And Discontinued Operation | $72.8m | $85.1m | ($95.6m) | $45.1m | $1.3m | $70.7m | ($54.6m) | ($11.9m) | ($168.1m) | ($77.9m) | ($76.1m) | |
| Net loss on disposals, consolidations and deconsolidations | — | $2.4m | $31.8m | ($4.4m) | $5.7m | $2.2m | $11.1m | $14.4m | $40.6m | $30.4m | — | |
| Net loss attributable to Surgery Partners, Inc. | $1.4m | $9.5m | ($205.7m) | ($74.8m) | ($116.1m) | ($70.9m) | ($54.6m) | ($11.9m) | ($168.1m) | ($77.9m) | — | |
| Net Income Continuous Operations | — | — | — | — | — | — | $87.0m | $135.3m | $12.5m | $98.9m | $97.1m | |
| Less: Net income attributable to non-controlling interests | ($71.4m) | ($75.6m) | ($110.1m) | ($119.9m) | ($117.4m) | ($141.6m) | ($141.6m) | ($147.2m) | ($180.6m) | ($176.8m) | — | |
| Net Income (Loss) Attributable to Parent | $1.4m |
$9.5m
+561.51%
|
($205.7m)
-2276.09%
|
($74.8m)
+63.64%
|
($116.1m)
-55.21%
|
($70.9m)
+38.93%
|
($54.6m)
+22.99%
|
($11.9m)
+78.21%
|
($168.1m)
-1312.61%
|
($77.9m)
+53.66%
|
($76.1m)
+2.31%
|
|
| Net Income (Loss) Available to Common Stockholders, Basic | $72.8m |
$85.1m
+16.80%
|
($238.1m)
-379.88%
|
($110.5m)
+53.60%
|
($155.6m)
-40.81%
|
($81.2m)
+47.81%
|
($54.6m)
+32.76%
|
($11.9m)
+78.21%
|
$12.5m
+205.04%
|
$98.9m
+691.20%
|
($76.1m)
-176.95%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | $71.4m | $75.6m | $110.1m | $119.9m | $117.4m | $141.6m | $141.6m | $147.2m | $180.6m | $176.8m | ($76.1m) | |
| Undistributed Earnings (Loss) Allocated to Participating Securities, Basic | — | — | $32.4m | $35.7m | $39.5m | $10.3m | $0 | — | — | — | — | |
| Otherunder Preferred Stock Dividend | — | — | — | — | — | $10.3m | $0 | $0 | — | — | — | |
| Earnings Per Share, Basic | $0.04 | $0.20 | ($4.96) | ($2.29) | ($3.19) | ($1.12) | ($0.59) | ($0.09) | ($1.33) | ($0.61) | ($0.59) | |
| Earnings Per Share, Diluted | $0.04 | $0.20 | ($4.96) | ($2.29) | ($3.19) | ($1.12) | ($0.59) | ($0.09) | ($1.33) | ($0.61) | ($0.59) | |
| Basic (shares) | $36.1m | $48.0m | $48.0m | $48.3m | $48.8m | $72.4m | $92.0m | $125.6m | $126.1m | $127.2m | $127.7m | |
| Diluted (shares) | $37.5m | $48.2m | $48.0m | $48.3m | $48.8m | $72.4m | $92.0m | $125.6m | $126.1m | $127.2m | $127.7m | |
| Weighted Average Number of Shares Outstanding, Basic | 36.1m | 48.0m | 48.0m | 48.3m | 48.8m | 72.4m | 92.0m | 125.6m | 126.1m | 127.2m | 127.7m | |
| Basic Average Shares | $36.1m | $48.0m | $48.0m | $48.3m | $48.8m | $72.4m | $92.0m | $125.6m | $126.1m | $127.2m | $127.7m | |
| Diluted Average Shares | $36.1m | $48.0m | $48.0m | $48.3m | $48.8m | $72.4m | $92.0m | $125.6m | $126.1m | $127.2m | $127.7m | |
| Weighted Average Number of Shares Outstanding, Diluted | 37.5m | 48.2m | 48.0m | 48.3m | 48.8m | 72.4m | 92.0m | 125.6m | 126.1m | 127.2m | 127.7m | |
| Additional Financial Items | ||||||||||||
| Goodwill, Impairment Loss | $0 | $0 | — | $5.4m | $5.4m | $0 | $0 | $0 | $0 | $0 | — | |
| Depreciation Amortization Depletion Income Statement | $34.5m | $39.6m | $67.4m | $76.5m | $94.8m | $98.8m | $114.8m | $118.1m | $152.6m | $176.0m | $178.2m | |
| Depreciation And Amortization In Income Statement | $34.5m | $39.6m | $67.4m | $76.5m | $94.8m | $98.8m | $114.8m | $118.1m | $152.6m | $176.0m | $178.2m | |
| Diluted EPS | $0.04 | $0.20 | ($4.96) | ($2.29) | ($3.19) | ($1.12) | ($0.59) | ($0.09) | ($1.33) | ($0.61) | ($0.59) | |
| Diluted NI Availto Com Stockholders | $72.8m | $85.1m | ($95.6m) | $45.1m | $1.3m | $70.7m | ($54.6m) | ($11.9m) | ($168.1m) | ($77.9m) | ($76.1m) | |
| Earnings From Equity Interest | $3.8m | $4.8m | $8.9m | $10.2m | $10.8m | $11.3m | $12.5m | $14.2m | $19.5m | $22.9m | $21.4m | |
| Minority Interests | ($71.4m) | ($75.6m) | ($110.1m) | ($119.9m) | ($117.4m) | ($141.6m) | ($141.6m) | ($147.2m) | ($180.6m) | ($176.8m) | ($173.2m) | |
| Normalized EBITDA | — | — | — | — | — | — | $504.2m | $548.3m | $646.4m | $678.4m | $571.6m | |
| Normalized Income | — | — | — | — | — | — | ($19.7m) | $68.8m | ($53.5m) | $17.6m | $10.9m | |
| Other Gand A | $56.0m | $60.2m | $93.6m | $88.6m | $97.1m | $104.0m | $102.2m | $120.9m | $138.7m | $118.2m | — | |
| Other Special Charges | — | — | — | — | — | — | ($14.4m) | $26.1m | $4.3m | $8.6m | — | |
| Reconciled Depreciation | $34.5m | $39.6m | $67.4m | $76.5m | $94.8m | $98.8m | $114.8m | $118.1m | $152.6m | $176.0m | $178.2m | |
| Selling General And Administration | $56.0m | $60.2m | $93.6m | $88.6m | $97.1m | $104.0m | $102.2m | $120.9m | $138.7m | $118.2m | — | |
| Special Income Charges | — | — | — | — | — | — | ($44.2m) | ($102.2m) | ($145.0m) | ($112.9m) | ($102.0m) | |
| Tax Effect Of Unusual Items | — | — | — | — | — | — | ($9.3m) | ($21.5m) | ($30.4m) | ($17.4m) | ($15.0m) | |
| Tax Provision | ($149.0m) | $7.1m | $26.5m | $9.5m | ($20.1m) | $10.5m | $23.3m | ($300k) | $134.6m | $18.0m | $16.8m | |
| Tax Rate For Calcs | — | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | |
| Write Off | — | — | — | — | — | $0 | $0 | — | — | — | $0 | |
| Salaries and benefits | $261.7m | $357.2m | $534.7m | $550.0m | $550.3m | $644.3m | $746.4m | $793.8m | $907.5m | $971.0m | — | |
| Supplies | $242.1m | $269.2m | $490.3m | $507.9m | $538.4m | $636.4m | $709.7m | $745.0m | $812.9m | $878.9m | — | |
| Professional and medical fees | $66.6m | $81.2m | $145.5m | $154.8m | $191.4m | $230.0m | $269.2m | $296.8m | $357.1m | $404.5m | — | |
| Equity in earnings of unconsolidated affiliates | ($3.8m) | ($4.8m) | ($8.9m) | ($10.2m) | ($10.8m) | ($11.3m) | ($12.5m) | ($14.2m) | ($19.5m) | ($22.9m) | — | |
| Litigation settlements | $0 | ($14.1m) | $46.0m | $200k | $1.2m | $0 | ($29.3m) | $10.6m | ($800k) | $7.3m | — | |
| Loss on debt extinguishment | $16.1m | $11.9m | $0 | $11.7m | $0 | $9.1m | $14.9m | $15.5m | $5.1m | $1.3m | — | |
| Business Combination, Acquisition Related Costs | — | $2.2m | — | $2.8m | $6.6m | — | $1.1m | $3.2m | — | — | — | |
| Costs and Expenses | — | — | — | $1.6b | — | — | — | — | — | — | — | |
| Other Cost and Expense, Operating | $54.1m | $61.5m | $104.3m | $109.3m | $112.8m | $132.4m | $156.7m | $175.3m | $201.7m | $201.4m | — | |
| Operating Expense | — | — | — | — | — | — | $217.0m | $239.0m | $291.3m | $294.2m | $298.0m | |
| Rent Expense Supplemental | $44.8m | $52.1m | $86.7m | $85.6m | $87.4m | $90.6m | $82.4m | $84.9m | $89.5m | $87.9m | $90.1m | |
| Lease expense | $44.8m | $52.1m | $86.7m | $85.6m | $87.4m | $90.6m | $82.4m | $84.9m | $89.5m | $87.9m | — | |
| Transaction and integration costs | $17.9m | $8.7m | $31.7m | $19.0m | $23.2m | $39.8m | $47.5m | $61.7m | $100.1m | $73.9m | — | |
| Total Unusual Items | — | — | — | — | — | — | ($44.2m) | ($102.2m) | ($145.0m) | ($112.9m) | ($102.0m) | |
| Total Expenses | — | — | — | — | — | — | $2.2b | $2.3b | $2.7b | $2.8b | $2.9b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.